SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton

Development

Volumn 139, Issue 5, 2012, Pages 948-957

  Langdon, Yvette ^a,b   Tandon, Panna ^a,b   Paden, Erika ^a   Duddy, Jennifer ^b   Taylor, Joan M ^a,b   Conlon, Frank L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocyte; Heart development; Xenopus

Indexed keywords

ACTIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 1; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE M PHASE; CYTOSKELETON; DISEASE ASSOCIATION; EMBRYO; GENE MUTATION; HEART DEVELOPMENT; HEART INJURY; HEART MUSCLE CELL; JUVENILE MYELOMONOCYTIC LEUKEMIA; MOLECULAR MECHANICS; NONHUMAN; NOONAN SYNDROME; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; XENOPUS;

ACTIN CYTOSKELETON; ANIMALS; ENZYME ACTIVATION; HEART; HUMANS; MUTATION, MISSENSE; MYOCARDIUM; MYOCYTES, CARDIAC; NOONAN SYNDROME; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RHO-ASSOCIATED KINASES; XENOPUS LAEVIS;

EID: 84856747091     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.067579     Document Type: Article

References (59)

1. Ahuja, P., Perriard, E., Pedrazzini, T., Satoh, S., Perriard, J. C. and Ehler, E. (2007). Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp. Cell Res. 313, 1270-1283
2. Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O. and Caroni, P. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805-809
3. Bennett, A. M., Hausdorff, S. F., O'Reilly, A. M., Freeman, R. M. and Neel, B. G. (1996). Multiple requirements for SHPTP2 in epidermal growth factormediated cell cycle progression. Mol. Cell. Biol. 16, 1189-1202
4. Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J. et al. (2004). Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820
5. Brown, D. D., Christine, K. S., Showell, C. and Conlon, F. L. (2007). Small heat shock protein Hsp27 is required for proper heart tube formation. Genesis 45, 667-678
6. Burnette, D. T., Manley, S., Sengupta, P., Sougrat, R., Davidson, M. W., Kachar, B. and Lippincott-Schwartz, J. (2011). A role for actin arcs in the leading-edge advance of migrating cells. Nat. Cell Biol. 13, 371-381
7. Chang, J., Xie, M., Shah, V. R., Schneider, M. D., Entman, M. L., Wei, L. and Schwartz, R. J. (2006). Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc. Natl. Acad. Sci. USA 103, 14495-14500
8. Digilio, M. C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A. and Dallapiccola, B. (2002). Grouping of multiplelentigines/ LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet. 71, 389-394
9. Doggrell, S. A. (2005). Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opin. Investig. Drugs 14, 1157-1159
10. Feng, G. S. (1999). Shp-2 tyrosine phosphatase: signaling one cell or many. Exp. Cell Res. 253, 47-54
11. Fishman, M. C. and Chien, K. R. (1997). Fashioning the vertebrate heart: earliest embryonic decisions. Development 124, 2099-2117
12. Fragale, A., Tartaglia, M., Wu, J. and Gelb, B. D. (2004). Noonan syndromeassociated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum. Mutat. 23, 267-277
13. Fukata, Y., Oshiro, N., Kinoshita, N., Kawano, Y., Matsuoka, Y., Bennett, V., Matsuura, Y. and Kaibuchi, K. (1999). Phosphorylation of adducin by Rhokinase plays a crucial role in cell motility. J. Cell Biol. 145, 347-361
14. Georgescu, M. M., Kirsch, K. H., Kaloudis, P., Yang, H., Pavletich, N. P. and Hanafusa, H. (2000). Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res. 60, 7033-7038
15. Goetz, S. C., Brown, D. D. and Conlon, F. L. (2006). TBX5 is required for embryonic cardiac cell cycle progression. Development 133, 2575-2584
16. Hahn, A., Heusinger-Ribeiro, J., Lanz, T., Zenkel, S. and Goppelt-Struebe, M. (2000). Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J. Biol. Chem. 275, 37429-37435
17. Harvey, R. P. (2002). Patterning the vertebrate heart. Nat. Rev. Genet. 3, 544-556
18. Haudek, S. B., Gupta, D., Dewald, O., Schwartz, R. J., Wei, L., Trial, J. and Entman, M. L. (2009). Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc. Res. 83, 511-518
19. Iwamoto, H. (2000). Influence of ionic strength on the actomyosin reaction steps in contracting skeletal muscle fibers. Biophys. J. 78, 3138-3149
20. Kolker, S., Tajchman, U. and Weeks, D. L. (2000). Confocal Imaging of early heat development in Xenopus laevis. Dev. Biol. 218, 64-73
21. Kosaki, K., Suzuki, T., Muroya, K., Hasegawa, T., Sato, S., Matsuo, N., Kosaki, R., Nagai, T., Hasegawa, Y. and Ogata, T. (2002). PTPN11 (proteintyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. J. Clin. Endocrinol. Metab. 87, 3529-3533
22. Kosako, H., Yoshida, T., Matsumura, F., Ishizaki, T., Narumiya, S. and Inagaki, M. (2000). Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene 19, 6059-6064
23. Kratz, C. P., Niemeyer, C. M., Castleberry, R. P., Cetin, M., Bergstrasser, E., Emanuel, P. D., Hasle, H., Kardos, G., Klein, C., Kojima, S. et al. (2005). The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 106, 2183-2185
24. Langdon, Y. G., Goetz, S. C., Berg, A. E., Swanik, J. T. and Conlon, F. L. (2007). SHP-2 is required for the maintenance of cardiac progenitors. Development 134, 4119-4130
25. Lee, H. H. and Chang, Z. F. (2008). Regulation of RhoA-dependent ROCKII activation by Shp2. J. Cell Biol. 181, 999-1012
26. Legius, E., Schrander-Stumpel, C., Schollen, E., Pulles-Heintzberger, C., Gewillig, M. and Fryns, J. P. (2002). PTPN11 mutations in LEOPARD syndrome. J. Med. Genet. 39, 571-574
27. Lin, T., Zeng, L., Liu, Y., DeFea, K., Schwartz, M. A., Chien, S. and Shyy, J. Y. (2003). Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ. Res. 92, 1296-1304
28. Loh, M. L., Reynolds, M. G., Vattikuti, S., Gerbing, R. B., Alonzo, T. A., Carlson, E., Cheng, J. W., Lee, C. M., Lange, B. J. and Meshinchi, S. (2004). PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia 18, 1831-1834
29. Loirand, G., Guerin, P. and Pacaud, P. (2006). Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98, 322-334
30. Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., Obinata, T., Ohashi, K., Mizuno, K. and Narumiya, S. (1999). Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898
31. Maheshwari, M., Belmont, J., Fernbach, S., Ho, T., Molinari, L., Yakub, I., Yu, F., Combes, A., Towbin, J., Craigen, W. J. et al. (2002). PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13. Hum. Mutat. 20, 298-304
32. Mohun, T., Orford, R. and Shang, C. (2003). The origins of cardiac tissue in the amphibian, Xenopus laevis. Trends Cardiovasc. Med. 13, 244-248
33. Mohun, T. J., Leong, L. M., Weninger, W. J. and Sparrow, D. B. (2000). The morphology of heart development in Xenopus laevis. Dev. Biol. 218, 74-88
34. Musante, L., Kehl, H. G., Majewski, F., Meinecke, P., Schweiger, S., Gillessen-Kaesbach, G., Wieczorek, D., Hinkel, G. K., Tinschert, S., Hoeltzenbein, M. et al. (2003). Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardiofacio-cutaneous syndrome. Eur. J. Hum. Genet. 11, 201-206
35. Nieuwkoop, P. D. and Faber, J. (1975). Normal Table of Xenopus laevis (Daudin). Amsterdam, The Netherlands: North Holland.
36. Noonan, J. A. (1968). Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am. J. Dis. Child 116, 373-380
37. Noonan, J. A. (1994). Noonan syndrome. An update and review for the primary pediatrician. Clin. Pediatr. 33, 548-555
38. Pawson, T. (1994). Tyrosine kinase signalling pathways. Princess Takamatsu Symp. 24, 303-322
39. Qu, C. K. (2000). The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res. 10, 279-288
40. Rikitake, Y., Oyama, N., Wang, C. Y., Noma, K., Satoh, M., Kim, H. H. and Liao, J. K. (2005). Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation 112, 2959-2965
41. Saxton, T. M. and Pawson, T. (1999). Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2. Proc. Natl. Acad. Sci. USA 96, 3790-3795
42. Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G. S. and Pawson, T. (1997). Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352-2364
43. Schildmeyer, L. A., Braun, R., Taffet, G., Debiasi, M., Burns, A. E., Bradley, A. and Schwartz, R. J. (2000). Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J. 14, 2213-2220
44. Shea, K. F., Wells, C. M., Garner, A. P. and Jones, G. E. (2008). ROCK1 and LIMK2 interact in spread but not blebbing cancer cells. PLoS ONE 3, e3398
45. Smith, J. C. and Slack, J. M. W. (1983). Dorsalization and neural induction: properties of the organizer in Xenopus laevis. J. Embryol. Exp. Morphol. 78, 299-317
46. Tang, T. L., Freeman, R. M., Jr, O'Reilly, A. M., Neel, B. G. and Sokol, S. Y. (1995). The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80, 473-483
47. Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S. et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465-468
48. Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., Brunner, H. G., Bertola, D. R., Crosby, A., Ion, A. et al. (2002). PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70, 1555-1563
49. Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J. D. and Gelb, B. D. (2003). Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148-150
50. Vahebi, S., Kobayashi, T., Warren, C. M., de Tombe, P. P. and Solaro, R. J. (2005). Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ. Res. 96, 740-747
51. Van Vactor, D., O'Reilly, A. M. and Neel, B. G. (1998). Genetic analysis of protein tyrosine phosphatases. Curr. Opin. Genet. Dev. 8, 112-126
52. Wang, N., Guan, P., Zhang, J. P., Chang, Y. Z., Gu, L. J., Hao, F. K., Shi, Z. H., Wang, F. Y. and Chu, L. (2011). Preventive effects of fasudil on adriamycininduced cardiomyopathy: possible involvement of inhibition of RhoA/ROCK pathway. Food Chem. Toxicol. 49, 2975-2982
53. Wei, L., Roberts, W., Wang, L., Yamada, M., Zhang, S., Zhao, Z., Rivkees, S. A., Schwartz, R. J. and Imanaka-Yoshida, K. (2001). Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development 128, 2953-2962
54. Wilson, P. A. and Hemmati-Brivanlou, A. (1995). Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 376, 331-333
55. Yang, W., Klaman, L. D., Chen, B., Araki, T., Harada, H., Thomas, S. M., George, E. L. and Neel, B. G. (2006a). An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317-327
56. Yang, W., Klaman, L. D., Chen, B., Araki, T., Harada, H., Thomas, S. M., George, E. L. and Neel, B. G. (2006b). An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317-327
57. Yokoyama, T., Goto, H., Izawa, I., Mizutani, H. and Inagaki, M. (2005). Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM). Genes Cells 10, 127-137
58. Zhang, J., Somani, A. K. and Siminovitch, K. A. (2000). Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12, 361-378
59. Zhao, Z. and Rivkees, S. A. (2003). Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev. Dyn. 226, 24-32.